Geetika Bhatt, MD
Medical Oncology · Jacksonville, FLNPI 1205193349
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Daiichi Sankyo Inc. at 57.6% of the total. 2025 is the largest year on record at $718, 2.8 times the $255 reported in 2019. That places this record below the midpoint for medical oncology clinicians in FL, where the typical reported total is $8,890.
Across 24 payments — averaging $46.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$650
- Edwards Lifesciences$84
- Merck$69
- AstraZeneca$59
- Genentech USA, Inc.$40
- Lilly USA, LLC$28
- plus $197 from 11 others
What the payments were for
- Consulting fees$65058%
- Food & beverage$42338%
- Education$545%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $650 |
| Edwards Lifesciences | 1 | $84 |
| Merck | 4 | $69 |
| AstraZeneca | 2 | $59 |
| Genentech USA, Inc. | 3 | $40 |
| Lilly USA, LLC | 2 | $28 |
| Sanofi | 1 | $25 |
| EMD Serono, Inc. | 1 | $23 |
| Biogen | 1 | $21 |
| Clovis Oncology, Inc. | 1 | $19 |
| Puma Biotechnology, Inc. | 1 | $19 |
| Amgen | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Gilead | 1 | $16 |
| Foundation Medicine, Inc. | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VANFLYTa$650
How this compares
$1,128 in reported general payments places this provider in the 15th percentile of 507 medical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Jacksonville
- Neil LoveMiami$5.6M
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
- Yasser KhaledOrlando$444K
- Judah FriedmanPalm Beach Gardens$416K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.